Ángel has more than 18 years of international experience in the biopharmaceutical industry, with responsibilities spanning business development, mergers and acquisitions (M&A), licensing, corporate strategy and commercial leadership at companies including Johnson & Johnson, Takeda, Sanofi, Valeant and Reckitt Benckiser. He has held positions in Singapore, Zurich, Paris and Madrid.
He has extensive experience in the assessment of investment opportunities, corporate development, business strategy and the launch of innovative initiatives within the life sciences sector. He currently serves as CEO of Tetraneuron, where he is driving the development of gene therapies for Alzheimer’s disease and other neurodegenerative disorders.